HD-OPM Archive
Topics › Statins

25 statin RCTs: about 75 mg/dL lower LDL cut heart attack and stroke risk about 40%

Louis Nervegna · Oct 17, 2025 · ♥ 7 reactions · 2 comments · original Facebook post
StatinsLDL, ApoB & lipid panelHeart attack, stroke & procedures
↻ This is a repost. The main version (highest ranked) is 25 statin RCTs: about 75 mg/dL LDL lowering cut heart attack and stroke roughly 40% · Dec 11, 2024.
AI summary & key facts

Louis shares a graph of all statin RCTs to 2016 (excluding those under 6 months or with fewer than 50 events) showing every one reduced major adverse cardiac events. A reduction of about 75 mg/dL in LDL lowered MACE risk by roughly 40%, with larger reductions in the 7 primary-prevention trials than the 18 secondary-prevention trials.

(no text — see the shared post below)

Research cited

As of 2016, twenty five different randomized-controlled trials each independently showed that statins reduce major adverse cardiac events (MACE), like heart attacks and strokes.

Here are all 25 of them— summarized on one graph.

There is no cherry picking here. This is every RCT conducted on statins up to 2016– except those lasting less than 6 months or with less than 50 adverse clinical events— only very short or small trials were excluded.

A lowering in LDL level of about 75mg/dL (1.9mmol/L) from the statin reduced the risk of having a heart attack or stroke (MACE) by about 40% on average, as compared to people taking a placebo.

(For example, someone with an LDL of 100mg/dL taking a statin in these trials would have a 40% lower risk of having a heart attack or stroke (MACE) on average than someone with LDL of 175mg/dL taking a placebo.)

To understand how this translates into a large reduction in absolute risk over the long term, see this post:

↪ Statin absolute risk reduction is cumulative: 1-2% in trials, far more over a lifetime

Seven of these clinical trials were primary prevention trials— participants who never had a heart attack or stroke before— as shown on the graph (circles). Notice that the risk reductions for the 7 primary prevention trials (circles) were even larger than the risk reductions for the 18 secondary prevention trials (squares).

Since 2016, even more clinical trials on statins have corroborated this.

This is WHY statins are now the standard of care in cardiology.

Note that 40mg/dL of LDL corresponds to about 1mmol/L.

Reference for this graph:

PaperAssociation Between Lowering LDL C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta analysisresearchgate.net

#statinsHD #statinrctsHD #ldlrctsHD #ldlHD #cacHD

No photo description available.
← newer: Statin benefit is cumulative: small short-trial risk cuts grolder: Post mocks a statin critic's criticism of the US president's →